Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab

Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab

We evaluated neoadjuvant ipilimumab in patients with surgically operable regionally advanced melanoma in order to define markers of activity in the blood and tumor as assessed at baseline (before ipilimumab) and early on-treatment. Patients were treated with ipilimumab (10 mg/kg intravenously every...

Full description

Bibliographic Details
Main Authors: Tarhini, Ahmad A., Edington, Howard, Butterfield, Lisa H., Lin, Yan, Shuai, Yongli, Tawbi, Hussein, Sander, Cindy, Yin, Yan, Holtzman, Matthew, Johnson, Jonas, Rao, Uma N. M., Kirkwood, John M.
Format: Online
Language:English
Published: Public Library of Science 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912016/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912016/

Similar Items